From the website dedicated to breast cancer research, geicam.orgThey give some data: “According to the last Data collected According to the European Cancer Information System (ECIS), in 2020 a total of 34,088 new cases of breast cancer were diagnosed in Spain, this type of tumor being the most frequent among women in our country due to against colorectal, uterine, lung and ovarian cancer.
And it is that although we are increasingly aware of the importance of early detection of this type of cancer, we should not get lost, much less relax. Until now if there were suspicions that a woman could have mom cancer because a physical change in the breast was detected through a mammogram, this could only be confirmed through a biopsy.
Now, thanks to some Spanish researchers, there is another way to do it: liquid biopsy which, as explained from 20 minutes, “It is a non-invasive procedure that consists of DNA analysis by massive sequencing, which allows the detection of the presence of DNA released by tumor cells into the blood.”
Liquid biopsy, a minimally invasive procedure
A procedure that also changes the discomfort of a traditional biopsy for a simple puncture, since it is performed with a blood sample. Speaking to EFEthe oncologist Luis Paz AresExplain: «It is a minimally invasive procedure, without the complications that conventional biopsies usually entail. In addition, it makes it possible to follow the evolution of patient treatment in real time, as well as to plan a more personalized treatment both before” and during the process”.
And they refer to the statements of Iñaki Comino-Méndezwho has led the research that has coordinated Emile Albahead of service of the Oncology Clinical Management Unit Intercentres of the Málaga Regional and Virgen de la Victoria university hospitalsin which he says that “Using this new technology, blood samples of 75 patients who presented mammograms with indications of breast cancer have been analysed, prior to any medical intervention. The results revealed that “the fact of presenting a detectable tumor mutation in the blood means that this woman has an 86% probability of having a breast tumor.”
The researcher also talks about the importance of this type of very “powerful” test when detecting tumors in asymptomatic individuals, as well as being key in choosing the most appropriate therapy for each patient. He also highlights that “It will be very important for patients thanks to its ability to detect the disease early and its subsequent early treatment.”
